APA (7th ed.) Citation

F, C., E, D. G., F, I., F, L., C, A., E, P., . . . A, B. (2016). Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial. BMC cancer, 16(1), 918. https://doi.org/10.1186/s12885-016-2957-y

Chicago Style (17th ed.) Citation

F, Caponigro, et al. "Phase II Clinical Study of Valproic Acid Plus Cisplatin and Cetuximab in Recurrent And/or Metastatic Squamous Cell Carcinoma of Head and Neck-V-CHANCE Trial." BMC Cancer 16, no. 1 (2016): 918. https://doi.org/10.1186/s12885-016-2957-y.

MLA (9th ed.) Citation

F, Caponigro, et al. "Phase II Clinical Study of Valproic Acid Plus Cisplatin and Cetuximab in Recurrent And/or Metastatic Squamous Cell Carcinoma of Head and Neck-V-CHANCE Trial." BMC Cancer, vol. 16, no. 1, 2016, p. 918, https://doi.org/10.1186/s12885-016-2957-y.